ArticleRheumatology (Oxford, England)2026
A simple questionnaire to prevent blindness: a cross-sectional study screening for Stickler syndrome in children.
Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesStickler syndrome is a skeletal dysplasia that is widely under-recognized yet the most common cause of inherited retinal detachment in children. The most prevalent subtype is Stickler syndrome type 1 (STL1), with an autosomal dominant variant in COL2A1 typically resulting in ophthalmic, orofacial, auditory and musculoskeletal manifestations. However, manifestations across these domains are not as prominent in children, making identification of individuals suitable for further assessment difficult. Thus, we sought to test an easy-to-use screening tool capable of differentiating children with STL1 from the general paediatric population.
methodsChildren aged 4-10 years with and without COL2A1-confirmed STL1 were recruited from a single specialist centre and online via the national patient support group Stickler Syndrome UK (Registered Charity number 1060421). A screening tool was administered, and planned analysis of the median final score and individual components of the questionnaire was completed.
resultsTwenty-six general paediatric and twenty-eight STL1 participants were recruited. STL1 participants scored higher on screening tool final score with a median score (IQR) of 7 (3.5) vs 0 [1], which was statistically significant on a Mann-Whitney U test (P < 0.001). The sensitivity and specificity were 93% and 96%, respectively, and STL1 participants were more likely to have myopia, palate abnormalities, family history of cleft palate and hypermobility on secondary analysis of the individual screening tool components (Hochberg-corrected all P < 0.005).
conclusionWe demonstrate a clinically powerful screening tool capable of identifying children with underlying STL1, and thus this questionnaire can now be applied to at-risk children to inform the need for further specialist assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.